{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:09:58Z","timestamp":1777093798631,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR063049"],"award-info":[{"award-number":["AR063049"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR068160"],"award-info":[{"award-number":["AR068160"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK045227"],"award-info":[{"award-number":["DK045227"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.metabol.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T06:19:15Z","timestamp":1503555555000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9154-952X","authenticated-orcid":false,"given":"Ernesto","family":"Canalis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2017.08.002_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/mcne.1996.0040","article-title":"Expression patterns of Jagged, Delta1, Notch1, Notch2, and Notch3 genes identify ligand-receptor pairs that may function in neural development","volume":"8","author":"Lindsell","year":"1996","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.metabol.2017.08.002_bb0010","doi-asserted-by":"crossref","first-page":"11785","DOI":"10.1074\/jbc.M708424200","article-title":"Localization of the delta-like-1-binding site in human Notch-1 and its modulation by calcium affinity","volume":"283","author":"Cordle","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.08.002_bb0015","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1128\/MCB.24.21.9265-9273.2004","article-title":"Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats","volume":"24","author":"Sanchez-Irizarry","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2009.03.045","article-title":"The canonical Notch signaling pathway: unfolding the activation mechanism","volume":"137","author":"Kopan","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2017.08.002_bb0025","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1128\/MCB.01285-09","article-title":"Notch and the Skeleton","volume":"30","author":"Zanotti","year":"2010","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0030","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1038\/onc.2008.223","article-title":"More complicated than it looks: assembly of Notch pathway transcription complexes","volume":"27","author":"Kovall","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.metabol.2017.08.002_bb0035","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.sbi.2006.11.004","article-title":"Structures of CSL, Notch and Mastermind proteins: piecing together an active transcription complex","volume":"17","author":"Kovall","year":"2007","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development","volume":"284","author":"Artavanis-Tsakonas","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.metabol.2017.08.002_bb0045","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.biocel.2005.06.013","article-title":"CSL: a Notch above the rest","volume":"37","author":"Pursglove","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0050","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/emboj\/18.8.2196","article-title":"Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation","volume":"18","author":"Ohtsuka","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2017.08.002_bb0055","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1128\/MCB.21.17.6080-6089.2001","article-title":"HERP, a novel heterodimer partner of HES\/E(spl) in Notch signaling","volume":"21","author":"Iso","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jcp.10208","article-title":"HES and HERP families: multiple effectors of the Notch signaling pathway","volume":"194","author":"Iso","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.devcel.2017.04.001","article-title":"The canonical Notch signaling pathway: structural and biochemical insights into shape, sugar, and force","volume":"41","author":"Kovall","year":"2017","journal-title":"Dev Cell"},{"key":"10.1016\/j.metabol.2017.08.002_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1101\/gad.14.3.377","article-title":"Repression by suppressor of hairless and activation by Notch are required to define a single row of single-minded expressing cells in the Drosophila embryo","volume":"14","author":"Morel","year":"2000","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2017.08.002_bb0075","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.tibs.2007.09.002","article-title":"Bare rudiments of notch signaling: how receptor levels are regulated","volume":"32","author":"Wu","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.metabol.2017.08.002_bb0080","doi-asserted-by":"crossref","first-page":"34904","DOI":"10.1074\/jbc.M112.403287","article-title":"Characterization of CSL (CBF-1, Su(H), Lag-1) mutants reveals differences in signaling mediated by Notch1 and Notch2","volume":"287","author":"Yuan","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.08.002_bb0085","doi-asserted-by":"crossref","first-page":"6509","DOI":"10.1074\/jbc.M707000200","article-title":"NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells","volume":"283","author":"Bai","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.08.002_bb0090","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1242\/dev.122.7.2251","article-title":"Notch4\/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene","volume":"122","author":"Uyttendaele","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.metabol.2017.08.002_bb0095","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bone.2017.06.027","article-title":"Parathyroid hormone inhibits Notch signaling in osteoblasts and osteocytes","volume":"103","author":"Zanotti","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.08.002_bb0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1101\/gad.8.6.707","article-title":"Notch1 is essential for postimplantation development in mice","volume":"8","author":"Swiatek","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.metabol.2017.08.002_bb0105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1242\/dev.116.4.931","article-title":"Notch2: a second mammalian Notch gene","volume":"116","author":"Weinmaster","year":"1992","journal-title":"Development"},{"key":"10.1016\/j.metabol.2017.08.002_bb0110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1242\/dev.128.4.491","article-title":"Defects in development of the kidney, heart and eye vasculature in mice homozygous for a hypomorphic Notch2 mutation","volume":"128","author":"McCright","year":"2001","journal-title":"Development"},{"key":"10.1016\/j.metabol.2017.08.002_bb0115","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1038\/onc.2008.230","article-title":"Notch3: from subtle structural differences to functional diversity","volume":"27","author":"Bellavia","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.metabol.2017.08.002_bb0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/en.2012-1732","article-title":"Osteoblast lineage-specific effects of Notch activation in the skeleton","volume":"154","author":"Canalis","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2017.08.002_bb0125","doi-asserted-by":"crossref","first-page":"25614","DOI":"10.1074\/jbc.M113.470492","article-title":"Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling","volume":"288","author":"Canalis","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.08.002_bb0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1681\/ASN.2009040353","article-title":"Notch2 activation in the embryonic kidney depletes nephron progenitors","volume":"21","author":"Fujimura","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0135","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1182\/blood-2010-12-325944","article-title":"CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling","volume":"118","author":"Hampel","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.metabol.2017.08.002_bb0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1259\/0007-1285-21-241-42","article-title":"Cranio-skeletal dysplasia","volume":"21","author":"Hajdu","year":"1948","journal-title":"Br J Radiol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0145","first-page":"595","article-title":"Acro-osteolysis","volume":"94","author":"Cheney","year":"1965","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.metabol.2017.08.002_bb0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MCD.0000000000000034","article-title":"Hajdu-Cheney syndrome: phenotypical progression with de-novo NOTCH2 mutation","volume":"23","author":"Descartes","year":"2014","journal-title":"Clin Dysmorphol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13023-014-0200-y","article-title":"Hajdu-Cheney syndrome: a review","volume":"9","author":"Canalis","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.metabol.2017.08.002_bb0160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0002-9343(78)90851-3","article-title":"Hereditary osteodysplasia with acro-osteolysis. (The Hajdu-Cheney syndrome)","volume":"65","author":"Elias","year":"1978","journal-title":"Am J Med"},{"key":"10.1016\/j.metabol.2017.08.002_bb0165","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF03349553","article-title":"High turnover osteoporosis in acro-osteolysis (Hajdu-Cheney syndrome)","volume":"13","author":"Nunziata","year":"1990","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.metabol.2017.08.002_bb0170","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/art.1780290815","article-title":"Idiopathic familial acroosteolysis: histomorphometric study of bone and literature review of the Hajdu-Cheney syndrome","volume":"29","author":"Udell","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.metabol.2017.08.002_bb0175","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2016.08.025","article-title":"Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab","volume":"92","author":"Adami","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.08.002_bb0180","first-page":"43","article-title":"Hajdu-Cheney syndrome associated with severe cardiac valvular and conduction disease","volume":"4","author":"Kaler","year":"1990","journal-title":"Dysmorph Clin Genet"},{"key":"10.1016\/j.metabol.2017.08.002_bb0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.kjms.2012.10.009","article-title":"Hajdu-Cheney syndrome with ventricular septal defect","volume":"29","author":"Sargin","year":"2013","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.metabol.2017.08.002_bb0190","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ejhg.2011.125","article-title":"Serpentine fibula polycystic kidney syndrome is part of the phenotypic spectrum of Hajdu-Cheney syndrome","volume":"20","author":"Gray","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.metabol.2017.08.002_bb0195","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/humu.21563","article-title":"Serpentine fibula-polycystic kidney syndrome caused by truncating mutations in NOTCH2","volume":"32","author":"Isidor","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.metabol.2017.08.002_bb0200","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/BF01957530","article-title":"Serpentine fibula\u2014polycystic kidney syndrome and Melnick-Needles syndrome are different disorders","volume":"152","author":"Majewski","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.metabol.2017.08.002_bb0205","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng.778","article-title":"Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis","volume":"43","author":"Isidor","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2017.08.002_bb0210","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/humu.21546","article-title":"Mutations in NOTCH2 in families with Hajdu-Cheney syndrome","volume":"32","author":"Majewski","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.metabol.2017.08.002_bb0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng.779","article-title":"Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss","volume":"43","author":"Simpson","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2017.08.002_bb0220","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00198-013-2298-5","article-title":"Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome","volume":"24","author":"Zhao","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2017.08.002_bb0225","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bone.2012.10.027","article-title":"Severe osteoporosis and mutation in NOTCH2 gene in a woman with Hajdu-Cheney syndrome","volume":"52","author":"Stathopoulos","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.08.002_bb0230","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1349-7006.2009.01130.x","article-title":"Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma","volume":"100","author":"Lee","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.metabol.2017.08.002_bb0235","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2017.08.002_bb0240","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/ajmg.a.33510","article-title":"Hajdu-Cheney syndrome with severe dural ectasia","volume":"155A","author":"Avela","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.metabol.2017.08.002_bb0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3476(77)80763-4","article-title":"Familial osteosclerosis with abnormalities of the nervous system and meninges","volume":"90","author":"Lehman","year":"1977","journal-title":"J Pediatr"},{"key":"10.1016\/j.metabol.2017.08.002_bb0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/(SICI)1096-8628(19970613)70:3<229::AID-AJMG4>3.0.CO;2-R","article-title":"Lateral meningocele syndrome: three new patients and review of the literature","volume":"70","author":"Gripp","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.metabol.2017.08.002_bb0255","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/ajmg.a.34075","article-title":"Lateral meningocele syndrome and Hajdu-Cheney syndrome: different disorders with overlapping phenotypes","volume":"155A","author":"Gripp","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.metabol.2017.08.002_bb0260","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.a.36863","article-title":"Truncating mutations in the last exon of NOTCH3 cause lateral meningocele syndrome","volume":"167A","author":"Gripp","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.metabol.2017.08.002_bb0265","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/ajmg.a.37541","article-title":"Lateral meningocele (Lehman) syndrome: a child with a novel NOTCH3 mutation","volume":"170A","author":"Ejaz","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.metabol.2017.08.002_bb0270","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.moh.0000143965.90813.70","article-title":"T cell acute lymphoblastic leukemia\/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling","volume":"11","author":"Pear","year":"2004","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0275","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1074\/jbc.M115.685453","article-title":"Hajdu Cheney mouse mutants exhibit osteopenia, increased osteoclastogenesis and bone resorption","volume":"291","author":"Canalis","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.08.002_bb0280","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/en.2012-1925","article-title":"Notch suppresses nuclear factor of activated T cells (Nfat) transactivation and Nfatc1 expression in chondrocytes","volume":"154","author":"Zanotti","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2017.08.002_bb0285","first-page":"943","article-title":"Gamma secretase inhibitors of Notch signaling","volume":"6","author":"Olsauskas-Kuprys","year":"2013","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.metabol.2017.08.002_bb0290","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1128\/MCB.00299-08","article-title":"The association of Notch2 and NF-kappaB accelerates RANKL-induced osteoclastogenesis","volume":"28","author":"Fukushima","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0295","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1074\/jbc.M117.786129","article-title":"Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome","volume":"292","author":"Zanotti","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.08.002_bb0300","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bone.2016.04.012","article-title":"Osteoblast-specific Notch2 inactivation causes increased trabecular bone mass at specific sites of the appendicular skeleton","volume":"87","author":"Yorgan","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.08.002_bb0305","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(00)80054-0","article-title":"Deficient T cell fate specification in mice with an induced inactivation of Notch1","volume":"10","author":"Radtke","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2017.08.002_bb0310","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2010.01.004","article-title":"Notch signaling in the immune system","volume":"32","author":"Radtke","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2017.08.002_bb0315","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1128\/MCB.23.23.8637-8650.2003","article-title":"Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells","volume":"23","author":"Witt","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0320","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ni793","article-title":"Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells","volume":"3","author":"Tanigaki","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0325","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0330","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev.immunol.23.021704.115728","article-title":"Marginal zone B cells","volume":"23","author":"Pillai","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0335","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1074-7613(03)00111-0","article-title":"Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development","volume":"18","author":"Saito","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.metabol.2017.08.002_bb0340","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.4049\/jimmunol.171.6.2783","article-title":"Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells","volume":"171","author":"Witt","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0345","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.20132203","article-title":"Identification of a human splenic marginal zone B cell precursor with NOTCH2-dependent differentiation properties","volume":"211","author":"Descatoire","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2017.08.002_bb0350","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ni.3657","article-title":"Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10","volume":"18","author":"Hammad","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0355","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.20091990","article-title":"ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo","volume":"207","author":"Gibb","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2017.08.002_bb0360","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1084\/jem.20131026","article-title":"IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity","volume":"210","author":"Simonetti","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.metabol.2017.08.002_bb0365","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fimmu.2011.00063","article-title":"Marginal zone B-cells, a gatekeeper of innate immunity","volume":"2","author":"Zouali","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0370","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/ng.582","article-title":"Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci","volume":"42","author":"Stahl","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2017.08.002_bb0375","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1172\/JCI45976","article-title":"The cautionary tale of side effects of chronic Notch1 inhibition","volume":"121","author":"Ryeom","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2017.08.002_bb0380","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/19083","article-title":"A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain","volume":"398","author":"De Strooper","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2017.08.002_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2015.10.006","article-title":"Beyond gamma-secretase activity: the multifunctional nature of presenilins in cell signalling pathways","volume":"28","author":"Duggan","year":"2016","journal-title":"Cell Signal"},{"key":"10.1016\/j.metabol.2017.08.002_bb0390","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ccr.2013.02.020","article-title":"Selective blockade of transport via SERCA inhibition: the answer for oncogenic forms of Notch?","volume":"23","author":"Ilagan","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.metabol.2017.08.002_bb0395","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ccr.2013.03.001","article-title":"Interweaving the strands: beta-catenin, an HIV co-receptor, and Schwann cell tumors","volume":"23","author":"Largaespada","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.metabol.2017.08.002_bb0400","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature08543","article-title":"Direct inhibition of the NOTCH transcription factor complex","volume":"462","author":"Moellering","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2017.08.002_bb0405","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1074\/jbc.M800170200","article-title":"Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2017.08.002_bb0410","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2017.08.002_bb0415","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1210\/er.2016-1002","article-title":"Notch signaling and the skeleton","volume":"37","author":"Zanotti","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2017.08.002_bb0420","doi-asserted-by":"crossref","first-page":"e9094","DOI":"10.1371\/journal.pone.0009094","article-title":"Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors","volume":"5","author":"Aste-Amezaga","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2017.08.002_bb0425","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nature05313","article-title":"Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis","volume":"444","author":"Ridgway","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2017.08.002_bb0430","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1038\/nature08751","article-title":"Chronic DLL4 blockade induces vascular neoplasms","volume":"463","author":"Yan","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2017.08.002_bb0435","first-page":"283","article-title":"Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome","volume":"37","author":"Galli-Tsinopoulou","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/j.metabol.2017.08.002_bb0440","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00198-007-0461-6","article-title":"Integrated anti-remodeling and anabolic therapy for the osteoporosis of Hajdu-Cheney syndrome: 2-year follow-up","volume":"19","author":"McKiernan","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.metabol.2017.08.002_bb0445","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/hmg\/ddp057","article-title":"Notch signaling contributes to the pathogenesis of human osteosarcomas","volume":"18","author":"Engin","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2017.08.002_bb0450","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ccr.2014.07.023","article-title":"Notch activation as a driver of osteogenic sarcoma","volume":"26","author":"Tao","year":"2014","journal-title":"Cancer Cell"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517302081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517302081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:15:14Z","timestamp":1758428114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049517302081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":90,"alternative-id":["S0026049517302081"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2017.08.002","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and experimental aspects of notch receptor signaling: Hajdu-Cheney syndrome and related disorders","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}